Clinical Trial Update: Safety and Efficacy of Zanubrutinib in the Treatment of Antiphospholipid Syndrome With Secondary Thrombocytopenia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the safety and efficacy of zanubrutinib for antiphospholipid syndrome with secondary thrombocytopenia, with patient recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antiphospholipid Syndrome
• Thrombocytopenia

Drugs mentioned

• Zanubrutinib (zanubrutinib)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Antiphospholipid Syndrome, Thrombocytopenia | Phase 2 | Status: RECRUITING